What is LOPJLB’s current signal on RPRX?

LOPJLB’s latest quantitative signal on Royalty Pharma plc (RPRX) is SELL in a BEAR regime. Signals are updated daily.

What market regime is RPRX in?

Royalty Pharma plc (RPRX) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Royalty Pharma plc (RPRX) do?

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and dia…

Where is Royalty Pharma plc based / listed?

Royalty Pharma plc is based in US, listed on NASDAQ.

Royalty Pharma plc (RPRX)

COMPARE

Healthcare · Medical - Pharmaceuticals · NASDAQ · US

$56.93+1.28%Close

SELLBEAR · day 22

[SCORES & PROFILE]

FUND: 62
VALUE: 38
GROWTH: 51
GARP: 48
TYPE: Dividend Compounder

Composite of Value · Growth · GARP

ROIC7.4%

REV YoY-

ROE12.3%

EPS YoY-

ROA4.1%

GROSS

NET

[VALUATION]

P/E TTM23.42

P/E FWD11.14

SECTOR PE20.47

INDUSTRY PE108.47

P/B3.68

P/FCF-

EV/EBITDA19.33

EV/EBIT-

PEG1.52

FCF YIELD-

RISK

INT COV-

D/E131.16

ALTMAN Z-

CURR RATIO1.29

ND/EBITDA-

BETA0.43

Royalty Pharma plc (RPRX)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news